Full Text View
Tabular View
No Study Results Posted
Related Studies
Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature (Phoenix)
This study is ongoing, but not recruiting participants.
Study NCT00355030   Information provided by Eli Lilly and Company

First Received on July 18, 2006.   Last Updated on August 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Idiopathic Short Stature (ISS)
Additional conditions recognized in this trial
Dwarfism
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Endocrine System Diseases
Genetic Diseases, Inborn
Musculoskeletal Diseases
Interventions listed in this trial
somatropin
leuprorelin
Additional drug interventions recognized in this trial
Leuprolide
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Fertility Agents
Fertility Agents, Female
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services